Always a pleasure to join Kim Reiss Binder (Kim Reiss) on the podium to co-chair the GHP Oral Abstract Session! Practice changing updates in CRT for GE cancers, dual IO in 1L HCC, and RT in BTC. #ASCO24 Perlmutter Cancer Center at NYU Langone Health

#Research is #Hope and how we are moving #forward . There are many ongoing #TrialsInProgress presented at #ccfac24 . Part 1/2

Mitesh Borad, M.D. Angela Lamarca

NYU Langone’s Perlmutter Cancer Center has once again been designated as a Comprehensive Cancer Center by National Cancer Institute, further validating its state-of-the-art, research-based approaches to cancer care.

Learn more about this elite distinction: bit.ly/3W4Y2SB

Cholangiocarcinoma Trial Alert: CTEP #10276- can radiation + DNA-PK inhibitor + avelumab overcome resistance to checkpoint inhibitors? Stop by our poster! NCT04068194 #CCF2024 Cholangiocarcinoma Foundation Perlmutter Cancer Center at NYU Langone Health Salma Jabbour Janice Mehnert, MD

#ComboMATCH Treatment Trial E5, led by Kristen Spencer of Perlmutter Cancer Center at NYU Langone Health and Dustin Deming of UW Health | Carbone Cancer Center, is a randomized phase 2 study of #sotorasib with or without #panitumumab in advanced #SolidTumors . Learn more here: bit.ly/combomatch-e5 #PrecisionMedicine

No one more deserving of this award…congrats Dr. Kelley (ps - your Notorious BTC ladies and your huge fan club love you)!! Cholangiocarcinoma Foundation Stacie Lindsey Laura Goff Milind Javle Nina Shah Flavio G Rocha, MD, FACS, FSSO Kristen Spencer Anthony El-Khoueiry #CCF2024

March is colorectal cancer awareness month. Screening saves lives! Perlmutter Cancer Center at NYU Langone Health American Cancer Society

abc7ny.com/amp/colorectal…

#ComboMATCH Treatment Trial E5, led by Kristen Spencer of Perlmutter Cancer Center at NYU Langone Health and Dustin Deming of UW Health | Carbone Cancer Center, is a randomized phase 2 study of #sotorasib with or without #panitumumab in advanced #SolidTumors . Learn more here: bit.ly/combomatch-e5 #PrecisionMedicine

Took a stroll down memory lane and noted this all began in 2020! This has been a labor of love a long time in the making, and with the help of many of you it is finally a reality. How fitting it activated at #GI24 . I’m coming for you KRAS! Perlmutter Cancer Center at NYU Langone Health Dustin Deming ECOG-ACRIN Cancer Research Group

November is Pancreatic Cancer Awareness Month! 🎗💜

Change the course of this disease by raising awareness about early detection this month! Learn more: pancan.org/awareness #PanCANawareness

A legendary trial in the making! Congrats Michael Lidsky, MD, FACS

October is Liver Cancer Awareness Month!

Cholangiocarcinoma is the second most common liver cancer in the world and it is vital for this community to join in the conversation and learn more.

More info about CCA at curecca.org.
#OctoberIs4Livers #CCAhope #cureCCA

Proud to share the podium with many cholangiocarcinoma rockstars last weekend! Biomarkers in CCA- are we ready for prime time? #CCASummit2023 Flavio G Rocha, MD, FACS, FSSO Rachna Shroff, MD, MS, FASCO Milind Javle Cholangiocarcinoma Foundation Perlmutter Cancer Center at NYU Langone Health

Kicking off the 5th Anniversary #Cholangiocarcinoma Summit in Scottsdale, AZ 🌵 #CCA2023 Amplity Medical Communications

When we ask about ctDNA in pancreas cancer, let us also ask how we can offer better options to our patients? DAVA Oncology Perlmutter Cancer Center at NYU Langone Health PanCAN

Closing out the morning sessions is our CRC panel discussing checkpoint inhibition and other immune therapies. #DAVABermudaGI Frank Sinicrope, MD Kristen Spencer Mohamed E. Salem, MD, FASCO